News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Manuel Modiano

Articles by Manuel Modiano

88 Eflapegrastim, a Long-Acting Granulocyte Colony–Stimulating Factor, Administered the Same Day as Chemotherapy in Patients With Early-Stage Breast Cancer: Results From a Multicenter, Open-Label Study

ByLee Schwartzberg, MD, FACP,Omkar Marathe,Shanta Chawla,Jeffrey L. Vacirca,Kenneth Crist,Howard Franklin,Manuel Modiano

April 23rd 2025

Latest Updated Articles

Trending on CancerNetwork

FDA Permits Expanded Daraxonrasib Access in Previously Treated Metastatic PDAC

FDA Approves Vepdegestrant in ER+, HER2–, ESR1-Mutated Breast Cancer

FDA ODAC Votes No to Camizestrant for HR+/HER2– ESR1 Advanced Breast Cancer

TIP137 ADELA: A Double-blind, Placebo-Controlled, Randomized Phase 3 Trial of Elacestrant + Everolimus Versus Elacestrant + Placebo in ER+/HER2- Advanced Breast Cancer (aBC) Patients With ESR1-Mutated Tumors Progressing on Endocrine Therapy (ET) + CDK4/6i

Experts Analyze 6-Year Zanubrutinib Data Across CLL/SLL Settings